These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19544052)

  • 1. Subacute exposure to N-ethyl perfluorooctanesulfonamidoethanol results in the formation of perfluorooctanesulfonate and alters superoxide dismutase activity in female rats.
    Xie W; Wu Q; Kania-Korwel I; Tharappel JC; Telu S; Coleman MC; Glauert HP; Kannan K; Mariappan SV; Spitz DR; Weydert J; Lehmler HJ
    Arch Toxicol; 2009 Oct; 83(10):909-24. PubMed ID: 19544052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluorooctanesulfonate (PFOS) Conversion from N-Ethyl-N-(2-hydroxyethyl)-perfluorooctanesulfonamide (EtFOSE) in male Sprague Dawley rats after inhalation exposure.
    Chang S; Mader BT; Lindstrom KR; Lange CC; Hart JA; Kestner TA; Schulz JF; Ehresman DJ; Butenhoff JL
    Environ Res; 2017 May; 155():307-313. PubMed ID: 28260617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of N-ethyl-N-(2-hydroxyethyl)perfluorooctanesulfonamide by rat liver microsomes, cytosol, and slices and by expressed rat and human cytochromes P450.
    Xu L; Krenitsky DM; Seacat AM; Butenhoff JL; Anders MW
    Chem Res Toxicol; 2004 Jun; 17(6):767-75. PubMed ID: 15206897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorooctanoate, perflourooctanesulfonate, and N-ethyl perfluorooctanesulfonamido ethanol; peroxisome proliferation and mitochondrial biogenesis.
    Berthiaume J; Wallace KB
    Toxicol Lett; 2002 Mar; 129(1-2):23-32. PubMed ID: 11879971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation, biodegradation and toxicological effects of N-ethyl perfluorooctane sulfonamidoethanol on the earthworms Eisenia fetida exposed to quartz sands.
    Zhao S; Liu T; Wang B; Fu J; Liang T; Zhong Z; Zhan J; Liu L
    Ecotoxicol Environ Saf; 2019 Oct; 181():138-145. PubMed ID: 31176248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds.
    Case MT; York RG; Christian MS
    Int J Toxicol; 2001; 20(2):101-9. PubMed ID: 11354466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid.
    Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP
    Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antioxidant enzymes in ciprofibrate-induced oxidative stress.
    Dhaunsi GS; Singh I; Orak JK; Singh AK
    Carcinogenesis; 1994 Sep; 15(9):1923-30. PubMed ID: 7923586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats.
    Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW
    Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats.
    Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP
    Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of aerobic biotransformation pathways of a perfluorooctane sulfonate (PFOS) precursor in distinctly different soils.
    Zhang L; Lee LS; Niu J; Liu J
    Environ Pollut; 2017 Oct; 229():159-167. PubMed ID: 28595069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered fatty acid homeostasis and related toxicologic sequelae in rats exposed to dietary potassium perfluorooctanesulfonate (PFOS).
    Curran I; Hierlihy SL; Liston V; Pantazopoulos P; Nunnikhoven A; Tittlemier S; Barker M; Trick K; Bondy G
    J Toxicol Environ Health A; 2008; 71(23):1526-41. PubMed ID: 18923995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isomer-specific biotransformation of perfluorooctane sulfonamide in Sprague-Dawley rats.
    Ross MS; Wong CS; Martin JW
    Environ Sci Technol; 2012 Mar; 46(6):3196-203. PubMed ID: 22339592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
    Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
    Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of fluorochemical-induced mitochondrial dysfunction.
    Starkov AA; Wallace KB
    Toxicol Sci; 2002 Apr; 66(2):244-52. PubMed ID: 11896291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hepatic and thyroid responses in male Sprague Dawley rats for up to eighty-four days following seven days of dietary exposure to potassium perfluorooctanesulfonate.
    Elcombe CR; Elcombe BM; Foster JR; Chang SC; Ehresman DJ; Noker PE; Butenhoff JL
    Toxicology; 2012 Mar; 293(1-3):30-40. PubMed ID: 22239858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators.
    Reddy JK; Goel SK; Nemali MR; Carrino JJ; Laffler TG; Reddy MK; Sperbeck SJ; Osumi T; Hashimoto T; Lalwani ND
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1747-51. PubMed ID: 3456610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isomer-specific accumulation of perfluorooctanesulfonate from (N-ethyl perfluorooctanesulfonamido)ethanol-based phosphate diester in Japanese Medaka (Oryzias latipes).
    Peng H; Zhang S; Sun J; Zhang Z; Giesy JP; Hu J
    Environ Sci Technol; 2014 Jan; 48(2):1058-66. PubMed ID: 24364678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.
    Shipley JM; Hurst CH; Tanaka SS; DeRoos FL; Butenhoff JL; Seacat AM; Waxman DJ
    Toxicol Sci; 2004 Jul; 80(1):151-60. PubMed ID: 15071170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats.
    Leung LK; Glauert HP
    Toxicology; 1997 Nov; 123(1-2):101-9. PubMed ID: 9347925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.